Laura L Gibson

Laura L Gibson, MD, is a Professor at UMass Chan Medical School, affiliated with the T.H. Chan School of Medicine in the Pediatrics and Medicine departments. Her research focuses on human T cell responses to cytomegalovirus (CMV) in children and transplant recipients, transplant-related infections, and travel medicine. She also holds appointments in the Morningside Graduate School of Biomedical Sciences for Masters in Clinical Investigation and Population Health Sciences.

• Education:
  • BA in Arts, Yale University
  • MD, University of Massachusetts Medical School

Her work spans virology, immunology, infectious diseases, and public health, with notable contributions to understanding SARS-CoV-2 diagnostic performance and CMV immune responses. Recent studies include longitudinal analysis of vaccine breakthrough infections, digital health for home testing, and CMV-specific T cell epitope recognition in mother-infant pairs.

Research Trends: Her publications emphasize virology (SARS-CoV-2, CMV), immunology (T cell responses), public health (epidemiology, biorepositories), and molecular biology (gene therapy, viral evolution). Collaborative networks include experts in David McManus, Apurv Soni, and Bruce Barton.

Grants and Collaborative Work: Dr. Gibson leads initiatives like the RADx Tech Clinical Studies Core and co-designed the Test Us Bank biorepository. She contributes to digital health platforms for reporting test results and risk-based testing protocols.

Labs and Teams: She collaborates with multidisciplinary teams across UMass Chan Medical School, including the Infectious Diseases Division and Masters in Clinical Investigation program.